Showing 13,641 - 13,660 results of 107,116 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.45s Refine Results
  1. 13641

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  2. 13642

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  3. 13643

    Proteomic Analysis of the Murine Liver in Response to a Combined Exposure to Psychological Stress and 7,12-Dimethylbenz(a)anthracene by Melanie S. Flint (2263015)

    Published 2010
    “…Changes in protein abundances derived from spectral counting indicates that stress alone results in increases in the abundance of proteins responsive to oxidative stress, along with Phase I and II metabolizing enzymes, such as CYP2J5 and UDP glucoronytransferases. The proteomic results further indicate that exposure to DMBA induces increases in the abundance of CYP1A2 and serine protease inhibitors and decreases the abundance of CYP4 V3. …”
  4. 13644
  5. 13645
  6. 13646
  7. 13647
  8. 13648

    Image_5.TIF by Yumeng Shi (1351218)

    Published 2018
    “…</p>Results<p>Knockdown SOX5 decreased lamellipodium formation, migration, and invasion of RA-FLS. …”
  9. 13649

    Image_5.tif by Angelica Martins Batista (5086820)

    Published 2018
    “…Selective blockade of CCR1 (Met-RANTES therapy) in infected Ccr5<sup>−/−</sup> mice supported a protective role for CCR1 in CCC. …”
  10. 13650

    A representative result of 2D DIGE in a diver at 200 msw. by Hideharu Domoto (3221349)

    Published 2016
    “…The red spot indicated by a pink arrow was located at 32.4 kDa, pI 5.8 (ratio; 2.18). …”
  11. 13651
  12. 13652
  13. 13653
  14. 13654
  15. 13655
  16. 13656
  17. 13657

    DataSheet_1_Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzhe... by Eleni Fella (3925409)

    Published 2022
    “…We have previously administered the modified C5a receptor agonist (EP67) for a short period to a transgenic mouse model of AD (5XFAD) and have observed not only reduction in β-amyloid deposition and gliosis but also improvement in cognitive impairment. …”
  18. 13658
  19. 13659
  20. 13660